PPaX: Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi

Sponsor
Baylor College of Medicine (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02333227
Collaborator
(none)
9,365
1
2
92.1
101.7

Study Details

Study Description

Brief Summary

The hypothesis of the investigators' project is that comprehensive primary preterm birth prevention, inclusive of maternal oral health with xylitol chewing gum (the intervention), will reduce the rate of periodontal disease and caries, preterm birth prevalence, and neonatal mortality.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Xylitol gum
N/A

Detailed Description

Significance and Impact: Adverse birth outcomes related to the length of gestation (preterm birth) are recognized as one of the most significant disorders in maternal-child health at a global scale. In the developed world, the preterm birth rate approximates 7%. In Malawi, the investigators have recently demonstrated that this rate more than triples to approximate 26.1%. Of the 4 million newborn deaths annually, nearly 1/3 (27%) are directly attributable to prematurity with another 36% secondary to related opportunistic infections (sepsis, pneumonia, gastrointestinal). 75% of the 4 million deaths occur within the first week of life, with the vast majority occurring in the first 48 hours. For those that do survive, there are persistent and lifelong risks due to stunted growth, chronic infection, retinopathy of prematurity, and bronchopulmonary dysplasia. The link between maternal oral health (periodontal disease in particular) and risk of preterm birth has been demonstrated across all populations (rural and urban, in both industrialized and developing regions) studied to date. However, in multiple randomized controlled trials treatment of active periodontal disease with scaling and planning during pregnancy has failed to demonstrate a significant benefit in preventing preterm birth.

Why would maternal oral health impact preterm birth? In rodents, subcutaneous inoculations with periodontal pathogens cause dose-dependent decreases in pup weights, and elicit inflammatory responses that can trigger preterm birth when present in amniotic fluid. Periodontitis (defined as a destructive inflammation of the periodontium) has a prevalence of 30% or greater in women of child bearing age. By definition, it involves microbial infiltration of the periodontium, which stimulates a chronic inflammatory response, recurrent bacteremia, and the production of cytokines and prostaglandins which trigger risk of preterm birth. It is the same production of prostaglandins which are felt to mediate the risk of preterm birth. So if the investigators know that there is biologic evidence that periodontitis is related to preterm birth, but treating active periodontitis does not reduce these morbidities, is it possible that preventing periodontitis might prevent preterm birth and low birth weight? If so, what are the least expensive efficacious preventative measures? The investigators' overarching hypothesis is that comprehensive primary preterm birth prevention, inclusive of maternal oral health with xylitol chewing gum (the intervention), will reduce the rate of periodontal disease and caries, preterm birth prevalence, and neonatal mortality.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
9365 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi (Prevention of Prematurity and Xylitol)
Actual Study Start Date :
May 1, 2015
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Cluster of sites not receiving xylitol gum. This is a cluster randomized trial, whereby 4 sites will not receive the intervention of xylitol gum in the prepregnancy and early pregnancy interval.

Experimental: Xylitol

Cluster of sites receiving xylitol gum.

Dietary Supplement: Xylitol gum
This is a cluster randomized trial, whereby 4 sites will receive the intervention of xylitol gum in the prepregnancy and early pregnancy interval.

Outcome Measures

Primary Outcome Measures

  1. Rate of preterm birth [Conception to date of delivery, <37 weeks gestation]

    Measure rate of preterm birth <37 and <34 weeks gestation, as defined by best obstetrical estimate of last menstrual period consistent with <24 week sonogram, OR <24 week sonogram with unknown last menstrual period, OR skilled examination and <24 week sonogram.

  2. Number of infants <2000 grams [Date of delivery to 1 week postnatal]

    Measured weight at delivery to determine the rate of <2000 gram infants.

  3. Number of infants with adverse neonatal composite morbidity and mortality [Date of delivery to 30 days postnatal]

    Additive or singular composite neonatal morbidity of <2000 gram infants at 30 days of age. Composite neonatal morbidity and mortality outcomes are defined as: neonatal death, neonatal sepsis, neonatal respiratory distress requiring assisted ventilation (generally bubble CPAP in this region of Malawi), exogenous oxygen, necrotizing enterocolitis, and neonatal seizures.

Secondary Outcome Measures

  1. Prevalence of periodontal disease [Enrollment up to 5 years]

    We will measure the prevalence of periodontal disease among gravidae. We will use now standardized WHO oral health forms and disease scoring.

  2. Prevalence of dental caries [Enrollment up to 5 years]

    We will measure the prevalence of dental caries among gravidae. We will use now standardized WHO oral health forms and disease scoring.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Enrollment at <20 weeks gestation by best obstetrical estimate, or

  2. Enrollment post partum with an anticipated next pregnancy within 18 months, or

  3. Enrollment preconception with an anticipated pregnancy within 18 months (preconception); and

  4. Cognitively aware enough to participate in the study

  5. 18 years of age (in Malawi, constitutes a legal adult and capacity to consent for study)

  6. Willing to participate in the study

  7. Willing to undergo at least two periodontal exams

  8. Willing to chew 1 piece of xylitol gum for 10 minutes after the morning and evening meal (intervention sites)

  9. Anticipating to remain within the region for 18 months

Exclusion Criteria:
  1. 20 weeks gestation by best obstetrical estimate

  2. Post partum and not anticipating another pregnancy within 18 months

  3. Preconception and not anticipating another pregnancy within 18 months

  4. Not cognitively aware enough to participate in the study

  5. Not willing to undergo at least two periodontal exams

  6. <18 years of age

  7. Not willing to chew 1 piece of xylitol gum for 10 minutes after the morning and evening meal (intervention sites)

  8. Anticipating a move outside of the region within 18 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baylor College of Medicine Houston Texas United States 77030

Sponsors and Collaborators

  • Baylor College of Medicine

Investigators

  • Principal Investigator: Kjersti Aagaard, M.D., Baylor College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kjersti Aagaard, Associate Professor and Vice Chair of Research, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT02333227
Other Study ID Numbers:
  • NHSRC # 1030
  • H-35933
First Posted:
Jan 7, 2015
Last Update Posted:
Jan 14, 2021
Last Verified:
Jan 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2021